Have a feature idea you'd love to see implemented?
Let us know!
GRI GRI Bio Inc
Price (delayed)
$0.689
Market cap
$6.16M
P/E Ratio
0
Dividend/share
N/A
EPS
$579.59
Enterprise value
$1.54M
Highlights
The net income has grown by 38% YoY
GRI Bio's EPS has increased by 13% from the previous quarter
GRI's quick ratio has soared by 73% YoY but it is down by 3.5% QoQ
The equity has soared by 64% YoY but it has contracted by 22% from the previous quarter
Key stats
What are the main financial stats of GRI
Market
Valuations
Earnings
Shares outstanding
8.93M
Market cap
$6.16M
Enterprise value
$1.54M
Price to earnings (P/E)
0
Price to book (P/B)
0.55
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$8.29M
EBITDA
-$8.29M
Free cash flow
-$12.17M
Per share
Balance sheet
Liquidity
EPS
$579.59
Free cash flow per share
-$3.85
Book value per share
$1.25
Revenue per share
$0
TBVPS
$1.73
Total assets
$5.46M
Total liabilities
$1.8M
Debt
$131,000
Equity
$3.66M
Working capital
$3.61M
Debt to equity
0.04
Current ratio
3.1
Quick ratio
2.77
Net debt/EBITDA
0.56
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-165%
Return on equity
-289.1%
Return on invested capital
N/A
Return on capital employed
-221.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GRI stock price
How has the GRI Bio stock price performed over time
Intraday
7.82%
1 week
-28.23%
1 month
-47.8%
1 year
-99.24%
YTD
-98.03%
QTD
90.86%
Financial performance
How have GRI Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$8.31M
Net income
-$8.26M
Gross margin
N/A
Net margin
N/A
The net income has grown by 38% YoY
GRI Bio's operating income has increased by 25% YoY and by 3.6% from the previous quarter
Growth
What is GRI Bio's growth rate over time
Valuation
What is GRI Bio stock price valuation
P/E
0
P/B
0.55
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GRI Bio's EPS has increased by 13% from the previous quarter
The equity has soared by 64% YoY but it has contracted by 22% from the previous quarter
The price to book (P/B) is 63% lower than the last 4 quarters average of 1.5
Efficiency
How efficient is GRI Bio business performance
GRI's ROE has soared by 75% YoY and by 13% QoQ
The company's return on assets has surged by 61% YoY and by 5% QoQ
Dividends
What is GRI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GRI.
Financial health
How did GRI Bio financials performed over time
GRI's quick ratio has soared by 73% YoY but it is down by 3.5% QoQ
The current ratio has surged by 54% year-on-year
GRI Bio's debt is 96% less than its equity
The equity has soared by 64% YoY but it has contracted by 22% from the previous quarter
GRI's debt to equity is up by 33% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.